155 related articles for article (PubMed ID: 9586122)
1. Activities of tRNA-embedded dimeric minizymes.
Kuwabara T; Warashina M; Nakayama A; Ohkawa J; Taira K
Nucleic Acids Symp Ser; 1997; (37):307-8. PubMed ID: 9586122
[TBL] [Abstract][Full Text] [Related]
2. Formation of a catalytically active dimer by tRNA(Val)-driven short ribozymes.
Kuwabara T; Warashina M; Orita M; Koseki S; Ohkawa J; Taira K
Nat Biotechnol; 1998 Oct; 16(10):961-5. PubMed ID: 9788354
[TBL] [Abstract][Full Text] [Related]
3. Comparison of activities between hammerhead ribozymes and DNA enzymes targeted to L6 BCR-ABL chimeric (b2a2) mRNA.
Warashina M; Kuwabara T; Taira K
Nucleic Acids Symp Ser; 1997; (37):213-4. PubMed ID: 9586075
[TBL] [Abstract][Full Text] [Related]
4. Improved specificity of ribozyme-mediated cleavage of bcr-abl mRNA.
Kearney P; Wright LA; Milliken S; Biggs JC
Exp Hematol; 1995 Aug; 23(9):986-9. PubMed ID: 7543419
[TBL] [Abstract][Full Text] [Related]
5. Characterization of several kinds of dimer minizyme: simultaneous cleavage at two sites in HIV-1 tat mRNA by dimer minizymes.
Kuwabara T; Amontov SV; Warashina M; Ohkawa J; Taira K
Nucleic Acids Res; 1996 Jun; 24(12):2302-10. PubMed ID: 8710500
[TBL] [Abstract][Full Text] [Related]
6. Catalytic activities of hammerhead ribozymes with a triterpenoid linker instead of stem/loop II.
Sugiyama H; Hatano K; Saito I; Amontov S; Taira K
FEBS Lett; 1996 Sep; 392(3):215-9. PubMed ID: 8774847
[TBL] [Abstract][Full Text] [Related]
7. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
Kronenwett R; Haas R; Sczakiel G
J Mol Biol; 1996 Jun; 259(4):632-44. PubMed ID: 8683570
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA.
Kuwabara T; Warashina M; Tanabe T; Tani K; Asano S; Taira K
Nucleic Acids Res; 1997 Aug; 25(15):3074-81. PubMed ID: 9224607
[TBL] [Abstract][Full Text] [Related]
9. An intron promotes the anti-bcr-abl activities of a retrovirally expressed ribozyme in chronic myeloid leukemia cells.
Liu JH; Wu SC; Chen WS; Yen CC; Yang MH; Tsai YC; Chen PM
Biochem Biophys Res Commun; 2004 Jun; 318(3):764-72. PubMed ID: 15144904
[TBL] [Abstract][Full Text] [Related]
10. Maxizyme technology.
Iyo M; Kawasaki H; Taira K
Methods Mol Biol; 2004; 252():257-65. PubMed ID: 15017055
[TBL] [Abstract][Full Text] [Related]
11. A minimised hammerhead ribozyme with activity against interleukin-2 in human cells.
Sioud M; Opstad A; Hendry P; Lockett TJ; Jennings PA; McCall MJ
Biochem Biophys Res Commun; 1997 Feb; 231(2):397-402. PubMed ID: 9070287
[TBL] [Abstract][Full Text] [Related]
12. Dependence on Mg2+ ions of the activities of dimeric hammerhead minizymes.
Amontov S; Nishikawa S; Taira K
FEBS Lett; 1996 May; 386(2-3):99-102. PubMed ID: 8647298
[TBL] [Abstract][Full Text] [Related]
13. Purging of chronic myelogenous leukemia cells by retrovirally expressed anti-bcr-abl ribozymes with specific cellular compartmentalization.
Mendoza-Maldonado R; Zentilin L; Fanin R; Giacca M
Cancer Gene Ther; 2002 Jan; 9(1):71-86. PubMed ID: 11916246
[TBL] [Abstract][Full Text] [Related]
14. Maxizymes and small hairpin-type RNAs that are driven by a tRNA promoter specifically cleave a chimeric gene associated with leukemia in vitro and in vivo.
Oshima K; Kawasaki H; Soda Y; Tani K; Asano S; Taira K
Cancer Res; 2003 Oct; 63(20):6809-14. PubMed ID: 14583478
[TBL] [Abstract][Full Text] [Related]
15. Investigating and improving the specificity of ribozymes directed against the bcr-abl translocation.
James H; Mills K; Gibson I
Leukemia; 1996 Jun; 10(6):1054-64. PubMed ID: 8667643
[TBL] [Abstract][Full Text] [Related]
16. Design and in vitro activity of ribozymes against mRNA of a rat membrane inhibitor of complement.
Inui O; Tanaka T; Dohi N; Okada N; Okada H; Kikuchi Y
Nucleic Acids Symp Ser; 1997; (37):223-4. PubMed ID: 9586080
[TBL] [Abstract][Full Text] [Related]
17. Novel cleavage of a hammerhead ribozyme targeted to beta-amyloid peptide precursor mRNA.
Denman R; Miller DL
Arch Biochem Biophys; 1993 Sep; 305(2):392-400. PubMed ID: 8373177
[TBL] [Abstract][Full Text] [Related]
18. [Investigation on activities of hammerhead ribozyme embedded in genomic RNA of hepatitis delta virus].
Li XJ; Kuang ES; Dai W; Yang FH; Wang M; Wang HS; Zhou BP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):12-5. PubMed ID: 16201462
[TBL] [Abstract][Full Text] [Related]
19. Selective cleavage of bcr-abl chimeric RNAs by a ribozyme targeted to non-contiguous sequences.
Pachuk CJ; Yoon K; Moelling K; Coney LR
Nucleic Acids Res; 1994 Feb; 22(3):301-7. PubMed ID: 8127665
[TBL] [Abstract][Full Text] [Related]
20. Factors altering ribozyme-mediated cleavage of tumor necrosis factor-alpha mRNA in vitro.
Kisich KO; Freedland SJ; Erickson KL
Biochem Biophys Res Commun; 1997 Jul; 236(1):205-11. PubMed ID: 9223453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
